Why the study?
This study aimed to evaluate the clinical and genetic characteristics of pediatric LQTS patients at a single center, identifying common genetic variants, their phenotypic associations, and implications for management.
Population
50 pediatric patients with LQTS diagnosed between 2006 and 2024
Design
Single-center retrospective analysis
Key result
In pediatric patients with Long QT Syndrome, pathogenic mutations were associated with a significantly longer median QTc interval compared to patients without mutations (480 ms vs 458 ms, p<0.05).
Authors
Loading...
Supports genetic testing for risk stratification in pediatric LQTS; reinforces genotype-phenotype correlation.
Observational (n=50)
No
Effect estimate: r=0.403
Absolute Event Rate: 480% vs 458%
p-value: p=<0.05
In pediatric patients with Long QT Syndrome, pathogenic genetic mutations are present in about a third of cases and significantly correlate with longer QTc intervals, underscoring the value of genetic testing for risk stratification.
Jaskeviciute et al. (2026) conducted an observational in Congenital Long QT Syndrome (LQTS) (n=50). Pathogenic mutations vs. No mutations was evaluated on Median QTc interval (r=0.403, p=<0.05). In pediatric patients with Long QT Syndrome, pathogenic mutations were associated with a significantly longer median QTc interval compared to patients without mutations (480 ms vs 458 ms, p<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: